Introduction: Cigarette smoking can damage every organ in the body and is the leading
known preventable cause of death globally. It is estimated that 70% of patients want to quit …

ABSTRACT OBJECTIVE To review the evidence on the efficacy and safety of pharmacologic
and nonpharmacologic therapies for smoking cessation. QUALITY OF EVIDENCE …

Tobacco use disorder is a chronic illness. With its high comorbidity rate, it is a major cause of
years of life lost or years lived with disability; however, it is also considered the most …

Cigarette smoking is the most important modifiable risk factor for premature mortality. Many
common and serious diseases, including coronary artery disease, chronic obstructive lung …

Background: Many placebo-controlled trials have demonstrated the efficacy of individual
pharmacotherapies approved for smoking cessation. However, few direct or indirect …

After over two decades of intensive research, a variety of smoking cessation strategies, both
behavioral and pharmacotherapeutic, have been developed and clinically validated. In this …

Tobacco smoking remains the single most preventable cause of morbidity and mortality in
developed countries and poses a significant threat across developing countries where …

This article reviews the most common nonpharmacologic approaches used to support
smoking cessation and, where possible, provides estimates of their efficacy in controlled …

Promoting smoking cessation is among the key medical interventions aimed at reducing
worldwide morbidity and mortality in this century. Both behavioural counselling and …

Strategies for assisting smoking cessation include behavioural counselling to enhance
motivation and to support attempts to quit and pharmacological intervention to reduce …